CN101530516A - Chinese medicament for treating appendicitis - Google Patents

Chinese medicament for treating appendicitis Download PDF

Info

Publication number
CN101530516A
CN101530516A CN200910014806A CN200910014806A CN101530516A CN 101530516 A CN101530516 A CN 101530516A CN 200910014806 A CN200910014806 A CN 200910014806A CN 200910014806 A CN200910014806 A CN 200910014806A CN 101530516 A CN101530516 A CN 101530516A
Authority
CN
China
Prior art keywords
grams
chinese medicine
radix
rhizoma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910014806A
Other languages
Chinese (zh)
Other versions
CN101530516B (en
Inventor
王永
王军廷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009100148065A priority Critical patent/CN101530516B/en
Publication of CN101530516A publication Critical patent/CN101530516A/en
Application granted granted Critical
Publication of CN101530516B publication Critical patent/CN101530516B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicament for treating appendicitis. The Chinese medicament is characterized in that the Chinese medicament comprises the following raw materials in portion by weight: 6 to 100 grams of honeysuckle, 3 to 60 grams of dandelion, 2 to 30 grams of corydalis bungeana, 5 to 60 grams of scutellaria, 2 to 30 grams of rhizoma coptidis, 2 to 30 grams of cortex phellodendri, 2 to 30 grams of rhubarb, 3 to 60 grams of rhizoma corydalis, 2 to 30 grams of sargentgloryvine stem, 3 to 60 grams of matricaria indica, 2 to 30 grams of safflower, 2 to 30 grams of frankincense, 2 to 30 grams of myrrh, 2 to 30 grams of liquorice and 3 to 30 grams of tree peony bark. The Chinese medicament has the efficacies of antibiosis, antiphlogosis and acesodyne, relieves the obstruction of an appendiceal cavity and removes inflammatory exudates in the appendiceal cavity through the improvement of appendiceal blood circulation, stasis elimination, detumescence and promotion of intestinal peristalsis function, adopts a pure natural Chinese medicinal preparation, has no toxicity and no side effect on treatment, has good use and popularization value, avoids operation and develops a novel method for treating acute and chronic appendicitis.

Description

The typhlitic Chinese medicine of a kind of treatment
Technical field
The present invention relates to the typhlitic medicine of a kind of treatment, the typhlitic Chinese medicine of a kind of specifically treatment belongs to technical field of Chinese medicines.
Background technology
Appendicitis is a kind of commonly encountered diseases, frequently-occurring disease, is divided into acute appendicitis, chronic appendicitis according to clinical manifestation.Acute appendicitis is one of modal acute abdomen of surgery, is mostly to be caused by bacterial infection.Be sudden stomachache often clinically, many companion's beginnings around umbilicus, epigastrium, just inviolent during pain, increase the weight of gradually later on, and be transferred to right lower abdomen through suffering from abdominal pain after a few hours.Bottom right stomachache has tenderness or rebound tenderness, symptoms such as tension of abdominal muscle, and with nauseating, vomiting, heating etc.Chronic appendicitis mostly is acute transformation, also can begin to be chronic process.In treatment in the past surgical resection therapy be main, or venous transfusion, the medicine intramuscular injection, certain effect has all been received in the Chinese and western drugs treatment.But the complication that surgical resection therapy took place is unavoidable.As: 1, postoperative wound infection; 2, tissue adhesion; 3, appendiceal stump is left over long; 4, stomach wall nerve injury etc.
Summary of the invention
The objective of the invention is at the deficiencies in the prior art, provide a kind of can exempt patient operate on the operation the typhlitic Chinese medicine of treatment.
For addressing the above problem, the present invention by the following technical solutions:
The typhlitic Chinese medicine of a kind of treatment is characterized in that: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 6~100g, Herba Taraxaci 3~60g, Herba Violae 2~30g, Radix Scutellariae 5~60g, Rhizoma Coptidis 2~30g, Cortex Phellodendri 2~30g, Radix Et Rhizoma Rhei 2~30g, Rhizoma Corydalis 3~60g, Caulis Sargentodoxae 2~30g, Flos Chrysanthemi Indici 3~60g, Flos Carthami 2~30g, Olibanum 2~30g, Myrrha 2~30g, Radix Glycyrrhizae 2~30g, Cortex Moutan 3~30g.
Below be the scheme of further improvement in the technical proposal:
A kind of improvement project is: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 60g, Herba Taraxaci 30g, Herba Violae 10g, Radix Scutellariae 30g, Rhizoma Coptidis 10g, Cortex Phellodendri 10g, Radix Et Rhizoma Rhei 6g, Rhizoma Corydalis 10g, Caulis Sargentodoxae 15g, Flos Chrysanthemi Indici 10g, Flos Carthami 10g, Olibanum 9g, Myrrha 9g, Radix Glycyrrhizae 10g, Cortex Moutan 20g.
Another kind of improvement project is: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 6g, Herba Taraxaci 3g, Herba Violae 2g, Radix Scutellariae 5g, Rhizoma Coptidis 2g, Cortex Phellodendri 2g, Radix Et Rhizoma Rhei 2g, Rhizoma Corydalis 3g, Caulis Sargentodoxae 2g, Flos Chrysanthemi Indici 3g, Flos Carthami 2g, Olibanum 2g, Myrrha 2g, Radix Glycyrrhizae 2g, Cortex Moutan 3g.
Another improvement project is: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 100g, Herba Taraxaci 60g, Herba Violae 30g, Radix Scutellariae 60g, Rhizoma Coptidis 30g, Cortex Phellodendri 30g, Radix Et Rhizoma Rhei 30g, Rhizoma Corydalis 60g, Caulis Sargentodoxae 30g, Flos Chrysanthemi Indici 60g, Flos Carthami 30g, Olibanum 30g, Myrrha 30g, Radix Glycyrrhizae 30g, Cortex Moutan 30g.
The cold water of above-mentioned raw materials being put into 2.5L soaked 15 minutes, boil with moderate heat then, the back continuation of boiling uses slow fire boiling after 20~30 minutes, leach the about 250mL of medicinal liquid, and then in the medicine pot, add the cold water of 2L, boil the back with moderate heat and continue after 20~30 minutes, to leach the about 200mL of medicinal liquid, with the medicinal liquid mix homogeneously that leaches for twice with slow fire boiling.
Every day, potion divided morning, the preceding decoction being taken warmly of supper, and five days is a course of treatment, and can cure a course of treatment, and indivedual particular patients ' can be obeyed the after treatment course of treatment again for consolidating curative effect.The heavier person that suffers from abdominal pain can take western medicine tablet bendazol earlier.Attention is being taken the interim taboo of Chinese medicine of the present invention Fructus Capsici, shrimp paste, Eriocheir sinensis, there be not squama fish, cattle, donkey, Carnis Canitis, raw and cold thing and sexual life etc.
That Chinese prescription of the present invention has is antibiotic, antiinflammatory, analgesic effect, by improving vermiform appendix blood circulation, heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, promotion intestinal function wriggling, removes the vermiform appendix chamber and blocks, and gets rid of vermiform appendix intracavity inflammatory exudate.
Flos Lonicerae: its effect is a heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery, and this product mainly contains bios, and this rhinoceros straw colour elements etc. have broad-spectrum antibacterial action.
Herba Taraxaci: its effect is a heat-clearing and toxic substances removing, the medicinal powder for relieving pain knot, and this product mainly contains taraxacin, and taraxasterol etc. have significant bactericidal action to staphylococcus aureus.
Herba Violae: its effect is a heat-clearing and toxic substances removing, and this product mainly contains glycoside, flavonoid, and cerinic acids etc. have broad-spectrum antibacterial action.
Radix Scutellariae: its effect is a heat clearing and damp drying, clearing away heat and cooling blood, and this product contains baicalin, baicalin etc., and antimicrobial spectrum is wider.
Rhizoma Coptidis: its effect is a heat clearing and damp drying, the relieving restlessness that clears away heart-fire, eliminating fire and detoxication, and this product mainly contains berberine, coptisine etc., and wide antimicrobial spectrum is arranged.
Cortex Phellodendri: its effect is heat clearing and damp drying, eliminating fire and detoxication, reducing the minister-fire, and the main Han Xiao of this product Nie alkali, its antimicrobial spectrum is similar to Rhizoma Coptidis with antibacterial efficacy, and the effect of skin ulcer is treated in detoxifcation.
Radix Et Rhizoma Rhei: its effect is the long-pending intestinal stasis relieving of merit, purging fire and cooling blood, and blood circulation promoting and blood stasis dispelling, this product mainly contains anthraquinone analog compound, can stimulate large intestine, increases its propelling property wriggling and promotes defecation, and stronger broad-spectrum antibacterial action is arranged.
Rhizoma Corydalis: its effect is for invigorating blood circulation, circulation of qi promoting, and pain relieving, this product mainly contains Rhizoma Corydalis first element, second element, ugly element.Analgesic activity is remarkable, and calmness, hypnosis, spasmolysis are arranged.
Caulis Sargentodoxae: its major function is a heat-clearing and toxic substances removing, the promoting blood circulation and stopping pain effect.
Flos Chrysanthemi Indici: its main effect is a dispelling wind and heat pathogens, liver heat removing and eyesight improving, and this product contains adenine, choline, stachydrine etc., to staphylococcus aureus, Hemolytic streptococcus, dysentery bacterium, Bacillus typhi etc. all have antibacterial action.
Flos Carthami: its main effect is promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing.
Olibanum: its main effect is promoting blood circulation and stopping pain, detumescence and promoting granulation.
Myrrha: the same Olibanum of its main effect.
Radix Glycyrrhizae: its main effect is an invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, heat-clearing and toxic substances removing, relieving spasm to stop pain, the mediation property of medicine.
Cortex Moutan: its main effect is a clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, and this product is mainly paeonol, paeoniflorin, benzoic acid, sterols etc. all have inhibitory action to bacillus, coccus, dermatophytes.
The present invention is a raw material with the Chinese medicine material, has antibiotic, antiinflammatory, analgesic effect, not only fundamentally treats appendicitis, pain relieving is effective fast, be difficult for recurrence, and adopt the natural Chinese medicines preparation, treatment has no side effect, method is simple, safe, evident in efficacy, good value for applications is arranged, avoided operating on operation, off the beaten track in the acute and chronic appendicitis of treatment really.
Below in conjunction with the specific embodiment to technical scheme further instruction of the present invention:
The specific embodiment
From year October in May, 1978 to 2008, successively 456 routine acute appendicitiss, chronic appendicitis, abscess of appendix, suppurative appendicitis (in early days) are treated, male's 254 examples wherein, women's 202 examples, the oldest person 77 years old, reckling 7 years old, 42 years old mean age, be divided into treatment I, II, III group and matched group at random, every group 114 routine patient, treatment I, II, III group are taken the present invention's treatment and are made comparisons with the matched group that adopts conventional therapy.
Treatment I group adopts following therapeutic scheme: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 60g, Herba Taraxaci 30g, Herba Violae 10g, Radix Scutellariae 30g, Rhizoma Coptidis 10g, Cortex Phellodendri 10g, Radix Et Rhizoma Rhei 6g, Rhizoma Corydalis 10g, Caulis Sargentodoxae 15g, Flos Chrysanthemi Indici 10g, Flos Carthami 10g, Olibanum 9g, Myrrha 9g, Radix Glycyrrhizae 10g, Cortex Moutan 20g, the cold water of above-mentioned raw materials being put into 2.5L soaked 15 minutes, boil with moderate heat then, the back continuation of boiling uses slow fire boiling after 20~30 minutes, leach the about 250mL of medicinal liquid, and then in the medicine pot, add the cold water of 2L, boiling the back with moderate heat continues with slow fire boiling after 20~30 minutes, leach the about 200mL of medicinal liquid, with the medicinal liquid mix homogeneously that leaches for twice.Every day, potion divided morning, the preceding decoction being taken warmly of supper.
Treatment II group adopts following therapeutic scheme: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 6g, Herba Taraxaci 3g, Herba Violae 2g, Radix Scutellariae 5g, Rhizoma Coptidis 2g, Cortex Phellodendri 2g, Radix Et Rhizoma Rhei 2g, Rhizoma Corydalis 3g, Caulis Sargentodoxae 2g, Flos Chrysanthemi Indici 3g, Flos Carthami 2g, Olibanum 2g, Myrrha 2g, Radix Glycyrrhizae 2g, Cortex Moutan 3g, the cold water of above-mentioned raw materials being put into 2.5L soaked 15 minutes, boil with moderate heat then, the back continuation of boiling uses slow fire boiling after 20~30 minutes, leach the about 250mL of medicinal liquid, and then in the medicine pot, add the cold water of 2L, boiling the back with moderate heat continues with slow fire boiling after 20~30 minutes, leach the about 200mL of medicinal liquid, with the medicinal liquid mix homogeneously that leaches for twice.Every day, potion divided morning, the preceding decoction being taken warmly of supper.
Treatment III group adopts following therapeutic scheme: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 100g, Herba Taraxaci 60g, Herba Violae 30g, Radix Scutellariae 60g, Rhizoma Coptidis 30g, Cortex Phellodendri 30g, Radix Et Rhizoma Rhei 30g, Rhizoma Corydalis 60g, Caulis Sargentodoxae 30g, Flos Chrysanthemi Indici 60g, Flos Carthami 30g, Olibanum 30g, Myrrha 30g, Radix Glycyrrhizae 30g, Cortex Moutan 30g, the cold water of above-mentioned raw materials being put into 2.5L soaked 15 minutes, boil with moderate heat then, the back continuation of boiling uses slow fire boiling after 20~30 minutes, leach the about 250mL of medicinal liquid, and then in the medicine pot, add the cold water of 2L, boiling the back with moderate heat continues with slow fire boiling after 20~30 minutes, leach the about 200mL of medicinal liquid, with the medicinal liquid mix homogeneously that leaches for twice, every day, potion divided early, decoction being taken warmly before the supper.
Matched group adopts therapeutic scheme: typhlitic Therapeutic Method is treated in traditional not operating on.
The patient takes Chinese medicine of the present invention treatment time of a course of treatment, follows up a case by regular visits to every day once, comprises that symptom, sign improve situation, untoward reaction.The hemogram routine of seeking peace of having a medical check-up respectively before and after the treatment, the criterion of therapeutical effect relevant according to Ministry of Public Health bureau of drug administration is as follows:
Cure: symptom, sign disappear, and hemogram is normal, and B ultrasonic shows that enclosed mass disappears;
Effectively: symptom, sign are improved, and hemogram is normal, and B ultrasonic shows that bottom right abdomen enclosed mass obviously dwindles, and has light tenderness, no rebound tenderness;
Invalid: whole body and local symptom do not have improvement, and B ultrasonic shows that lump does not have obviously to be dwindled.
Draw through following up a case by regular visits to, in the treatment of a course of treatment, treatment I organizes 99 routine patient treatment recoveries from illness among the 114 routine patients, and 13 routine patient treatments are effective, and all the other patient treatments are invalid; Treatment II organizes 90 routine patient treatment recoveries from illness among the 114 routine patients, 22 routine patient treatments are effective, and all the other patient treatments are invalid; Treatment III organizes has 94 routine patients in the treatment recovery from illness among the 114 routine patients, 18 routine patient treatments are effective, and all the other patient treatments are invalid; 67 routine patient treatment recoveries from illness are arranged among the matched group 114 routine patients, and 12 routine patient treatments are effective, and all the other patient treatments are invalid; Therefore the therapeutic effect of treatment group obviously is better than matched group, and in three groups of treatment group, treatment I group is the optimum treatment scheme for therapeutic scheme.All cure patients again through the follow-up care in 2 years, none recurrence of the case of healing.All cure the patient again through the observation treatment in 5 years, and none recurrence of the case of healing is treated effective percentage and reached more than 98%.
Model case:
Case 1, grandson patient, the woman, 32 years old, transitivity bottom right stomachache 5 days, patient no obvious cause and inducement before 5 days the umbilicus periphery occurs bitterly, shift and be fixed on the bottom right abdomen after about one day, be persistence stomachache, paroxysmal increases the weight of, and the companion feels sick, vomiting, heating, comes the here diagnosis and treatment in that local clinic transfusion anti-infective therapy is invalid.
Health check-up: T39.4 ℃, R82 time/minute, P20 time/minute, BP15/10kpa.Patient middle age women, acute painful looks, abdomen is smooth, and abdominal muscle is tight, and bottom right abdomen mcBurney point is tenderness and rebound tenderness fixedly, touches enclosed mass, and liver, spleen do not touch, the Immobility voiced sound, the kidney district does not have the pain of kowtowing, and borborygmus is no abnormal.
Laboratory and auxiliary examination: blood routine examination WBC21.8 X 10 9/ L, N0.912, L0.088, RBC4.76 X 10 12/ L, HB135g/L, BT2 ', CT3 '.Abdominal B type ultrasonography is shown: liver, gallbladder, spleen, pancreas, two kidney no abnormality seen, and in the lower slightly echo district of spy of vermiform appendix district and 6.8 X 5.2cm sizes, owe clearly on the border, and it is even that interior echo is owed.
Diagnosis: acute simplex suppurative appendicitis.
Treatment: at first allow the oral bendazol 40mg of patient pain relieving, treated that stomachache was ended in about 27 minutes after, decoction being taken warmly Chinese medicine 250ml of the present invention, by second day early in the morning, early ante cibum the remaining 200ml Chinese medicine of decoction being taken warmly again, serve on five doses of recoveries from illness.
Case 2, patient Wang, man, 58 years old, cold because of general malaise, abdominal distention, evil at 5 o'clock in afternoon on May 28th, 1978, consideration is a common cold of gastrointestinal type, through taking hydroxytetracycline tablet 1g, dipyrone 1g, the commentaries on classics of not getting better after about 30 minutes, and begin pain around the umbilicus, be rest pain, paroxysmal increases the weight of, and transfers to bottom right abdomen ileocecus pain after about 10 minutes, mcBurney point local tenderness and rebound tenderness, be thought of as acute appendicitis, do not do auxiliary examination.Evening on the same day is through taking Chinese medicine potion of the present invention, approximately evening, 8 stomachache were ended, sxs such as general malaise, abdominal distention, evil are cold, the commentaries on classics but local tenderness of mcBurney point and rebound tenderness are not got better, be almost recovered through serveing on three doses of whole bodies and abdominal symptoms, but mcBurney point also has mild tenderness not have rebound tenderness, is after treatment, serve on two doses of recoveries from illness again, so far not recurrence.

Claims (4)

1. treat typhlitic Chinese medicine for one kind, it is characterized in that: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 6~100g, Herba Taraxaci 3~60g, Herba Violae 2~30g, Radix Scutellariae 5~60g, Rhizoma Coptidis 2~30g, Cortex Phellodendri 2~30g, Radix Et Rhizoma Rhei 2~30g, Rhizoma Corydalis 3~60g, Caulis Sargentodoxae 2~30g, Flos Chrysanthemi Indici 3~60g, Flos Carthami 2~30g, Olibanum 2~30g, Myrrha 2~30g, Radix Glycyrrhizae 2~30g, Cortex Moutan 3~30g.。
2, the typhlitic Chinese medicine of a kind of treatment according to claim 1 is characterized in that: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 6g, Herba Taraxaci 3g, Herba Violae 2g, Radix Scutellariae 5g, Rhizoma Coptidis 2g, Cortex Phellodendri 2g, Radix Et Rhizoma Rhei 2g, Rhizoma Corydalis 3g, Caulis Sargentodoxae 2g, Flos Chrysanthemi Indici 3g, Flos Carthami 2g, Olibanum 2g, Myrrha 2g, Radix Glycyrrhizae 2g, Cortex Moutan 3g.
3, the typhlitic Chinese medicine of a kind of treatment according to claim 1 is characterized in that: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 100g, Herba Taraxaci 60g, Herba Violae 30g, Radix Scutellariae 60g, Rhizoma Coptidis 30g, Cortex Phellodendri 30g, Radix Et Rhizoma Rhei 30g, Rhizoma Corydalis 60g, Caulis Sargentodoxae 30g, Flos Chrysanthemi Indici 60g, Flos Carthami 30g, Olibanum 30g, Myrrha 30g, Radix Glycyrrhizae 30g, Cortex Moutan 30g.
4, the typhlitic Chinese medicine of a kind of treatment according to claim 1 is characterized in that: described Chinese medicine comprises the raw material composition of following weight parts: Flos Lonicerae 60g, Herba Taraxaci 30g, Herba Violae 10g, Radix Scutellariae 30g, Rhizoma Coptidis 10g, Cortex Phellodendri 10g, Radix Et Rhizoma Rhei 6g, Rhizoma Corydalis 10g, Caulis Sargentodoxae 15g, Flos Chrysanthemi Indici 10g, Flos Carthami 10g, Olibanum 9g, Myrrha 9g, Radix Glycyrrhizae 10g, Cortex Moutan 20g.
CN2009100148065A 2009-04-22 2009-04-22 Chinese medicament for treating appendicitis Expired - Fee Related CN101530516B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100148065A CN101530516B (en) 2009-04-22 2009-04-22 Chinese medicament for treating appendicitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100148065A CN101530516B (en) 2009-04-22 2009-04-22 Chinese medicament for treating appendicitis

Publications (2)

Publication Number Publication Date
CN101530516A true CN101530516A (en) 2009-09-16
CN101530516B CN101530516B (en) 2011-08-17

Family

ID=41101512

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100148065A Expired - Fee Related CN101530516B (en) 2009-04-22 2009-04-22 Chinese medicament for treating appendicitis

Country Status (1)

Country Link
CN (1) CN101530516B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614419A (en) * 2012-04-09 2012-08-01 蒋金洲 Chinese medicinal pills for treating acute and chronic appendicitis
CN104707025A (en) * 2015-02-15 2015-06-17 周广生 Traditional Chinese medicine composition for treating chronic appendicitis
CN105770595A (en) * 2016-04-11 2016-07-20 杨新民 Traditional Chinese medicine formula for treating appendicitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056301C (en) * 1997-12-16 2000-09-13 曾火伟 'Lanweiling' oral liquid for treating appendicitis
CN101176768A (en) * 2006-11-10 2008-05-14 王玉林 Epityphlon health
CN101357179A (en) * 2008-08-23 2009-02-04 张红梅 Chinese traditional medicine for treating appendicitis and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614419A (en) * 2012-04-09 2012-08-01 蒋金洲 Chinese medicinal pills for treating acute and chronic appendicitis
CN102614419B (en) * 2012-04-09 2013-11-06 蒋金洲 Chinese medicinal pills for treating acute and chronic appendicitis
CN104707025A (en) * 2015-02-15 2015-06-17 周广生 Traditional Chinese medicine composition for treating chronic appendicitis
CN104707025B (en) * 2015-02-15 2018-01-05 周广生 A kind of Chinese medicine composition for treating chronic appendicitis
CN105770595A (en) * 2016-04-11 2016-07-20 杨新民 Traditional Chinese medicine formula for treating appendicitis

Also Published As

Publication number Publication date
CN101530516B (en) 2011-08-17

Similar Documents

Publication Publication Date Title
CN103230493B (en) Traditional Chinese medicine composition for treating unhealed wound
CN100333763C (en) Preparation method of bed sore flesh engendering ointment
CN101658610B (en) Chinese materia medica preparation for treating bedsore and preparation method thereof
CN103961552B (en) A kind of external-applied ointment and preparation method for the treatment of decubital ulcer
CN102319397A (en) Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method
CN103893557A (en) Traditional Chinese medicine preparation for treating bedsore
CN101530516B (en) Chinese medicament for treating appendicitis
CN102988555A (en) Skin and tissue cream for burns
CN102784343B (en) External use traditional Chinese medicine preparation for treating psoriasis
CN102078549A (en) Traditional Chinese medicine for treating oxyuriasis
CN103845617A (en) Medicament for treating latent glomerulonephritis
CN100368003C (en) Medicine for treating carbuncle and furuncle
CN102018874A (en) Traditional Chinese medicine preparation for treating swelling
CN1283282C (en) Chinese traditional medicine for treating appendicitis
CN103505539A (en) Formula of Chinese herbal medicine for treating scald
CN102423419B (en) External traditional Chinese preparation for treating bedsore
CN103239503A (en) Chinese medicine preparation for treating itai-itai disease and preparation method of Chinese medicine preparation
CN1048173C (en) Venereal disease curing powder medicine and method for preparing same
CN1305510C (en) Medicine for treating intractable fever
CN101890076B (en) Traditional Chinese medicine oral preparation for treating sores and ulcers
CN101703739A (en) Chinese medicinal linimentum for treating trauma and traumatic infection
CN1270748C (en) Chinese medicinal composition for treating sore and wound infection
CN1401350A (en) Medicine for treating burns and scald, and producing method thereof
CN105079404A (en) External traditional Chinese medicinal lotion for treating infective wound caused by multi-drug resistant bacteria
CN104857262A (en) Pure Chinese material medicine preparation for treating knife wounds and postoperative pyogenic infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110817

Termination date: 20180422

CF01 Termination of patent right due to non-payment of annual fee